Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 30 AUGUST 2023

China's New Rules For Generative AI: An Emerging Regulatory Framework

Fasken
Explore more from Fasken

On July 13, 2023, the Chinese government published its finalized rules on generative artificial intelligence, the Interim Measures for the Management of Generative Artificial Intelligence Services...

ChinaMedia, Telecoms, IT, Entertainment
Christopher Ferguson
Christopher Ferguson
Julie He
Julie He
Author LinkedIn connections

On July 13, 2023, the Chinese government published its finalized rules on generative artificial intelligence, the Interim Measures for the Management of Generative Artificial Intelligence Services ("Interim GAI Measures"), which came into effect on August 15, 2023 (Art. 24).1 The Interim GAI Measures were jointly approved by seven major Chinese government agencies, including the Ministry of Science and Technology, the Ministry of Public Security, and the Cyberspace Administration of China ("CAC"), Beijing's regulatory body for Internet matters. A draft version of the Interim GAI Measures was published in April 2023 to solicit public feedback.2

The objective of the Interim GAI Measures is to regulate generative AI, which is primarily designed to generate content, and they are the latest addition to an emerging framework of AI regulation in the People's Republic of China that already includes a number of application-specific and local laws. Chinese authorities

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

Related Comparative Guides

See more popular content from

Article

More Than Skin Deep: Ontario Considers A Makeover Of Cosmetic Injection Rules

A regulatory shift now under consideration in Ontario could reshape how the province’s medical aesthetic clinics operate. The proposal, which would change how nurses are authorized to administer medical aesthetic services, invites a broader look at how Ontario currently regulates cosmetic injections and how the proposed changes would align the province more closely with the regulatory frameworks already in place elsewhere in Canada. While these procedures are often marketed as routine “spa” services, they remain medical acts that involve prescription products and carry clinical risks.
CanadaFood, Drugs, Healthcare, Life Sciences
Fasken
Fasken
Article

Canada’s Counter-Tariffs On US Goods: A Primer On What Canadian Businesses Need To Know

Effective September 8, 2026, Canada implemented retaliatory tariffs on certain U.S. goods in response to the initial 50% tariffs imposed by the US under Section 338 of the Tariff Act of 1930. To operationalize these measures, the Canada Border Services Agency (CBSA) issued Customs Notice 26-23, establishing binding administrative rules on how the surtax will be applied, calculated, and collected.
CanadaInternational Law
Fasken
Fasken
Article

2026 Federal Budget: Highlights Affecting Financial Services

The 2026 Federal Budget (“Budget 2026”) proposes to grow the Canadian financial services sector, while introducing multiple checks on possible risks raised by new bank entrants and innovative technology. It also builds out existing policy measures to support digital innovation and combat fraud. There are various other measures that may be of interest to financial service providers in banking, insurance and payments.
CanadaFinance and Banking
Fasken
Fasken
Article

Open Banking Milestone: Draft Supervisory Guidelines For Consumer-Driven Banking Released

The Bank of Canada (the “Bank”) has published two proposed guidelines relating to the accreditation process for prospective participants under the Consumer-Driven Banking Framework: the Participating entity accreditation application requirements under the Consumer-Driven Banking Act (the “Participating Entity Guideline”) and the Third-party service provider accreditation application requirements under the Consumer-Driven Banking Act (the “TPSP Guideline”).
CanadaFinance and Banking
Fasken
Fasken
Article

Life Sciences-Health Canada Takes Action Against Unauthorized Peptide Sales

On July 29, 2026, Health Canada announced that it had obtained a permanent injunction against a Québec-based company in connection with the sale of unauthorized injectable peptides in Canada. The announcement reflects Health Canada’s continued focus on peptide products and serves as a reminder that injectable peptides intended for human use are regulated as prescription drugs and are subject to Canada's drug regulatory framework.
CanadaFood, Drugs, Healthcare, Life Sciences
Fasken
Fasken